FAS | SOXL | FAS / SOXL | |
Gain YTD | 19.134 | 5.122 | 374% |
Net Assets | 2.63B | 12B | 22% |
Total Expense Ratio | 0.89 | 0.75 | 119% |
Turnover | 19.00 | 145.00 | 13% |
Yield | 0.88 | 1.08 | 81% |
Fund Existence | 17 years | 15 years | - |
FAS | SOXL | |
---|---|---|
RSI ODDS (%) | N/A | 1 day ago90% |
Stochastic ODDS (%) | 1 day ago85% | 1 day ago90% |
Momentum ODDS (%) | 1 day ago90% | 1 day ago90% |
MACD ODDS (%) | 1 day ago90% | 1 day ago90% |
TrendWeek ODDS (%) | 1 day ago90% | 1 day ago90% |
TrendMonth ODDS (%) | 1 day ago90% | 1 day ago90% |
Advances ODDS (%) | 1 day ago90% | 1 day ago90% |
Declines ODDS (%) | 29 days ago90% | 9 days ago90% |
BollingerBands ODDS (%) | 1 day ago90% | 1 day ago90% |
Aroon ODDS (%) | 1 day ago90% | 1 day ago90% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BHYB | 54.70 | 0.11 | +0.20% |
Xtrackers USD High Yld BB-B ex Fin ETF | |||
PSF | 20.44 | 0.03 | +0.15% |
COHEN & STEERS SELECT PREFERRED AND Income FUND | |||
EATZ | 28.54 | N/A | N/A |
AdvisorShares Restaurant ETF | |||
FEDM | 56.82 | N/A | N/A |
FlexShares ESG&Clmt Dev Mkts ex-US Cr | |||
THNR | 22.76 | -0.08 | -0.34% |
Amplify Weight Loss Drug & Treatment ETF |
A.I.dvisor indicates that over the last year, FAS has been closely correlated with GS. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if FAS jumps, then GS could also see price increases.